Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Early-Stage Breast Cancer
Interventions: DRUG: Doxorubicin/Cyclophosphamide (AC) or Docetaxel/Cyclophosphamide (TC)
Sponsor: Duke University
Collaborators: United States Department of Defense